Pacific Biosciences of California Inc. sell StockNews.com
Start price
15.02.25
/
50%
€1.78
Target price
15.02.26
-
Performance (%)
-6.55%
Price
09.01.26
€1.66
Summary
This prediction is currently active. With a performance of -6.55%, the SELL prediction by StockNews_com is trending in the right direction. This prediction currently runs until 15.02.26. The prediction end date can be changed by StockNews_com at any time. StockNews_com has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Pacific Biosciences of California Inc. | 5.613% | 5.613% |
| iShares Core DAX® | 3.002% | 3.742% |
| iShares Nasdaq 100 | 2.966% | 1.308% |
| iShares Nikkei 225® | 5.606% | 4.472% |
| iShares S&P 500 | 2.312% | 1.880% |
Comments by StockNews_com for this prediction
In the thread Pacific Biosciences of California Inc. diskutieren
Pacific Biosciences of California, Inc. (NASDAQ: PACB) was upgraded by analysts at StockNews.com to a "sell" rating.
Ratings data for PACB provided by MarketBeat
Stopped prediction by StockNews_com for Pacific Biosciences of California Inc.
Pacific Biosciences of California Inc.
Start price
Target price
Perf. (%)
€1.39
18.04.24
18.04.24
-
18.04.25
18.04.25
-27.05%
19.04.25
19.04.25
Pacific Biosciences of California Inc.
Start price
Target price
Perf. (%)
€3.86
12.03.24
12.03.24
-
12.03.25
12.03.25
-69.22%
13.03.25
13.03.25
Pacific Biosciences of California Inc.
Start price
Target price
Perf. (%)
€5.85
13.01.24
13.01.24
-
13.01.25
13.01.25
-65.82%
14.01.25
14.01.25
Pacific Biosciences of California Inc.
Start price
Target price
Perf. (%)
€9.37
29.12.23
29.12.23
-
29.12.24
29.12.24
-80.02%
30.12.24
30.12.24